Fewer DNA Topoisomerase Ila Gene Copies in Doxorubicin-Resistant Cells
Author Information
Author(s): S Withoff, WN Keith, AJ Knol, JC Coutts, SF Hoare, NH Mulder, EGE de Vries
Primary Institution: University Hospital Groningen
Hypothesis
Does the decrease in DNA topoisomerase Ila gene copies contribute to mRNA decrease in doxorubicin-resistant cell lines?
Conclusion
The study concludes that the decrease in TopoIla gene copy number is associated with reduced TopoIla mRNA and protein levels in doxorubicin-resistant cell lines.
Supporting Evidence
- The study found that as resistance to doxorubicin increased, the number of TopoIla gene copies decreased.
- Fluorescence in situ hybridization showed that most cells in the resistant line had only two copies of the TopoIla gene.
- Previous studies indicated that reduced TopoIla levels are linked to drug resistance in cancer cells.
Takeaway
Some cancer cells become resistant to a drug called doxorubicin by having fewer copies of a gene that helps fight the drug, making it less effective.
Methodology
The study used fluorescence in situ hybridization and mRNA slot-blotting to analyze gene copy numbers and mRNA levels in various doxorubicin-resistant cell lines.
Limitations
The sensitivity of Southern blotting may not be sufficient to detect small changes in gene copy numbers.
Want to read the original?
Access the complete publication on the publisher's website